SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-19-035943
Filing Date
2019-02-12
Accepted
2019-02-12 16:16:03
Documents
2
Group Members
ARTAL GROUP S.A.ARTAL INTERNATIONAL MANAGEMENT S.A.ARTAL INTERNATIONAL S.C.A.ARTAL TREASURY LTDINVUS PUBLIC EQUITIES ADVISORS, LLCMR. PASCAL MINNESTICHTING ADMINISTRATIEKANTOOR WESTENDWESTEND S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d701823dsc13ga.htm SC 13G/A 150944
2 EXHIBIT 1 d701823dex991.htm EX-99.1 13740
  Complete submission text file 0001193125-19-035943.txt   166650
Mailing Address C/O THE INVUS GROUP, LLC 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022
Business Address C/O THE INVUS GROUP, LLC 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022 212-317-7520
Invus Public Equities, L.P. (Filed by) CIK: 0001340097 (see all company filings)

IRS No.: 980420215
Type: SC 13G/A

Mailing Address DARWINWEG 24 LEIDEN P7 2333CR
Business Address DARWINWEG 24 LEIDEN P7 2333CR 31(0)88 166 7000
ProQR Therapeutics N.V. (Subject) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88671 | Film No.: 19590986
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1